Future research on TILs is likely to focus on understanding their functional roles and interactions within the tumor microenvironment. Efforts are also being made to develop biomarkers that can predict the effectiveness of TILs in immunotherapy. Additionally, combining TIL-based therapies with other treatment modalities such as chemotherapy, radiotherapy, and targeted therapies is being explored to enhance therapeutic outcomes.
In summary, TILs play a crucial role in the immune response to cancer and are pivotal in both prognosis and treatment strategies. Advancements in histological techniques and a deeper understanding of TIL biology hold promise for improving cancer therapies and patient outcomes.
